mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.0094 |
0.8 |
mRNA |
palmostatin B |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.8 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
AT-406 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.8 |
mRNA |
VU0155056 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |